Navigation Links
IGC scientist awarded prestigious European Research Council Starting grant
Date:8/24/2009

Rui Costa, principal investigator of the Champalimaud Neuroscience Programme at the Instituto Gulbenkian de Ciencia (IGC), in Portugal, is one of only 219 recipients of the prestigious European Research Council Starting grants, out of 2503 applicants for the 2009 edition of this flagship award scheme. The grant, totalling close to 1.6 million euro, for a period of five years, will allow Rui Costa's young research team to pursue their research into the neurological mechanisms underlying goal-directed decision making behaviour, versus habit-based responses.

Rui Costa explains the aims of his research programme, 'We are daily, constantly having to make decisions and select appropriate actions to obtain specific goals. Actions may be selected on the basis of their consequences - for example, driving work with the aim of getting home. This type of goal-directed behaviour demands constant control and monitoring of those goals and consequences - an effortful endeavour. However, if we repeat the same action often enough, it may become automatic, that is, a habit, and the effort it requires may be reduced.'

'Habitual responses do not need constant evaluation of the consequences, and are often at play even when we wish to do something different - for example, we may wish to drive home from work, but end up somewhere else. There is increasing evidence that the neural circuits underlying goal-directed and habit-based decisions are different. Our aim is to establish the differences between these neural processes, both at the cellular and molecular level. To achieve this, we will be using cutting-edge molecular biology and electrophysiology (recording electrical activity in the brain) techniques. If we could unravel the processes whereby goal-directed and habit behaviour are determined, we would be closer to understanding not only decision-making processes, but also, obsessive behaviour disorders', adds Rui.

Indeed, this research may provide insight i
'/>"/>

Contact: Silvia Castro
sacastro@igc.gulbenkian.pt
351-214-464-537
Instituto Gulbenkian de Ciencia
Source:Eurekalert  

Page: 1 2

Related biology news :

1. UK scientists working to help cut ID theft
2. Scientists show that mitochondrial DNA variants are linked to risk factors for type 2 diabetes
3. Comet probes reveal evidence of origin of life, scientists claim
4. Scientists link fragile X tremor/ataxia syndrome to binding protein in RNA
5. Male elephants get photo IDs from scientists
6. Scientists retrace evolution with first atomic structure of an ancient protein
7. Muscle mass: Scientists identify novel mode of transcriptional regulation during myogenesis
8. Carnegie Mellon scientists develop nanogels that enable controlled delivery of carbohydrate drugs
9. Clemson scientists shed light on molecules in living cells
10. Scientists tackle mystery mountain illness
11. T. rex quicker than Becks, say scientists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
IGC scientist awarded prestigious European Research Council Starting grant
(Date:5/22/2013)... Adventitious changes in cellular DNA can endanger the whole ... cancer. Researchers at Ludwig-Maximilians-Universitaet (LMU) in Munich now report ... the double helix. , The DNA in our cells ... in our bodies. The instructions for this are encoded ... in DNA, the bases adenine (A), cytosine (C), guanine ...
(Date:5/22/2013)... responsible for legionellosis, an infectious disease that can lead ... has developed a complex method enabling it to camouflage ... these acting against the infectious bacteria. , Research led ... which teams from the National Institute of Health (NIH) ... Barcelona (BSC) have also participated, has described for the ...
(Date:5/22/2013)... UCLA life scientists provide important new details on how ... published online May 21 in the Journal of ... to making accurate predictions and informing policymakers of how ... , "There is a growing recognition among ... with one another, and that this is going to ...
Breaking Biology News(10 mins):DNA damage: The dark side of respiration 2Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5
... Policy Center is hosting a lecture and symposium Tuesday, ... better understand the disastrous floods of summer 2008. ... topic of this symposium in The Forkenbrock Series on ... the science of floods to the psychological impact of ...
... more than 30 million acres of agricultural land ... numbers have been increasing significantly since then. With ... seeking environmentally friendlier alternatives to conventional plastic mulch. ... higher yields, increased quality, improved disease and insect ...
... Otto, NC New research by U.S. Forest Service ... hemlock woolly adelgid is killing hemlock trees faster than ... carbon cycle of these forests. SRS researchers and cooperators ... the most recent issue of the journal Ecosystems ...
Cached Biology News:Public Policy Center hosts flood symposium March 10-12 2Biodegradable mulch films on the horizon 2Study finds hemlock trees dying rapidly, affecting forest carbon cycle 2
(Date:5/22/2013)... MA (PRWEB) May 22, 2013 Cambridge ... present at last week’s “Data Demonstration Day” on Capitol Hill, ... Semantics joined EMC, Google, Microsoft and others to showcase how ... proposed Digital Accountability and Transparency Act (DATA Act). , Originally ... Issa (R-CA) and Sen. Mark Warner ...
(Date:5/22/2013)... The Conference Forum announced ... Advance Clinical Trials conference taking place on September 19-20 ... , Disruptive thinkers from Novartis, Pfizer, Eli Lilly, ... approaches to reduce expensive infrastructure, engage patients and generate ... be big, or novel, or it must change the ...
(Date:5/22/2013)... YORK , May 22, 2013   ... the development of disease modifying therapeutics for Alzheimer,s ... the completion of its Series B financing, which ... and warrants that would represent approximately $2.8M in ... and new investors supported the raise. ...
(Date:5/22/2013)... May 22, 2013  Empire Genomics announced today ... patent pending novel genomic biomarker from Cornell University ... that could help in diagnosing and determining treatment ... Neuroendocrine prostate cancer (NEPC) is a ... arise de novo, but more commonly arises after ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Life Sciences,Holdings, Inc. (Nasdaq: ADLS ) a biopharmaceutical ... drugs in the,therapeutic areas of infection, cancer and respiratory ... Leaders Bank to increase,its line of credit from $4 ... of,maturity by 12 months to January 1, 2011. The ...
... Anadys Pharmaceuticals,Inc. (Nasdaq: ANDS ), a clinical-stage ... novel medicines in the areas of,hepatitis C and ... the third quarter ended September 30, 2008., ... of our hepatitis C,development programs," said Steve Worland ...
... CALGARY, Oct. 23 /PRNewswire-FirstCall/ - Oncolytics Biotech ... an abstract entitled "A Phase I,Study to ... Docetaxel in Patients with Advanced Malignancies" will ... Journal of Immunotherapy, the official,journal of the ...
Cached Biology Technology:Advanced Life Sciences Completes Debt Transaction 2Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 2Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 3Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 4Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 5Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 6Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 7Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights 8Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 2Oncolytics Biotech Inc. Collaborators to Present Combination REOLYSIN(R) and Docetaxel Results at iSBTc Annual Meeting 3
...
Mouse monoclonal antibody to PDK2 - pyruvate dehydrogenase kinase, isoenzyme 2...
Mouse polyclonal antibody raised against a partial recombinant WRB. NCBI Entrez Gene ID = 7485...
Mouse monoclonal antibody raised against a partial recombinant PRG4. NCBI Entrez Gene ID = PRG4...
Biology Products: